New York State Common Retirement Fund’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-20
| Closed | – | – | 3365 |
|
|
2024
Q2 | $0 | Sell |
20
-305
| -94% | – | ﹤0.01% | 3402 |
|
|
2024
Q1 | $6K | Hold |
325
| – | – | ﹤0.01% | 3211 |
|
|
2023
Q4 | $5K | Sell |
325
-1,170
| -78% | -$18K | ﹤0.01% | 3223 |
|
|
2023
Q3 | $74K | Buy |
1,495
+502
| +51% | +$24.8K | ﹤0.01% | 2877 |
|
|
2023
Q2 | $78K | Buy |
993
+677
| +214% | +$53.2K | ﹤0.01% | 3010 |
|
|
2023
Q1 | $29K | Sell |
316
-618
| -66% | -$56.7K | ﹤0.01% | 3075 |
|
|
2022
Q4 | $110K | Buy |
934
+361
| +63% | +$42.5K | ﹤0.01% | 2938 |
|
|
2022
Q3 | $104K | Buy |
573
+4
| +0.7% | +$726 | ﹤0.01% | 3005 |
|
|
2022
Q2 | $51K | Sell |
569
-3
| -0.5% | -$269 | ﹤0.01% | 3216 |
|
|
2022
Q1 | $89K | Sell |
572
-352
| -38% | -$54.8K | ﹤0.01% | 3052 |
|
|
2021
Q4 | $275K | Sell |
924
-2
| -0.2% | -$595 | ﹤0.01% | 2752 |
|
|
2021
Q3 | $534K | Sell |
926
-228
| -20% | -$131K | ﹤0.01% | 2426 |
|
|
2021
Q2 | $524K | Buy |
1,154
+228
| +25% | +$104K | ﹤0.01% | 2572 |
|
|
2021
Q1 | $498K | Buy |
926
+217
| +31% | +$117K | ﹤0.01% | 2467 |
|
|
2020
Q4 | $627K | Buy |
709
+357
| +101% | +$316K | ﹤0.01% | 2240 |
|
|
2020
Q3 | $223K | Buy |
+352
| New | +$223K | ﹤0.01% | 2598 |
|